Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets

Karl Bacos1, Alexander Perfilyev1, Alexandros Karagiannopoulos2

  • 1Epigenetics and Diabetes Unit, Department of Clinical Sciences and.

Insights

Researchers identified 395 genes with altered expression in pancreatic islets of individuals with type 2 diabetes (T2D). These gene expression changes contribute to beta cell dysfunction and T2D development.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Type 2 diabetes (T2D) is characterized by impaired insulin secretion from pancreatic beta cells.
  • Identifying genetic factors influencing T2D pathophysiology is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To identify novel candidate genes involved in T2D pathophysiology by analyzing gene expression in human pancreatic islets.
  • To investigate the functional relevance of identified genes in beta cell function and glucose homeostasis.

Main Methods:

  • Differential gene expression analysis in human pancreatic islets from ~300 individuals (T2D vs. non-diabetic).
  • Single-cell RNA-sequencing to determine gene expression in human beta cells.
  • Chromatin accessibility assays and association analysis with T2D single nucleotide polymorphisms (SNPs).
  • In vivo studies using mouse knockout models and functional validation of candidate genes (OPRD1, PAX5, SLC2A2) in beta cells.

Main Results:

  • 395 differentially expressed genes (DEGs) identified in T2D islets, including novel candidates (OPRD1, PAX5, TET1).
  • One-third of DEGs associated with HbA1c levels in individuals without diagnosed T2D, suggesting a predisposing role.
  • DEGs showed altered chromatin accessibility and association with T2D SNPs.
  • Mouse models confirmed the role of candidate genes in glucose homeostasis and body composition.
  • Functional studies revealed that altered OPRD1, PAX5, and SLC2A2 expression impairs insulin secretion, with PAX5-related impairment linked to mitochondrial dysfunction.
  • PAX5 identified as a potential transcriptional regulator of T2D-associated DEGs.

Conclusions:

  • Significant molecular alterations in human pancreatic islets contribute to beta cell dysfunction in T2D.
  • Identified DEGs, including novel candidates like PAX5, represent potential therapeutic targets for T2D.
  • PAX5 plays a critical role in beta cell function and may regulate multiple T2D-associated genes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K